Park, J., Joo, M. S., Kim, M. J., Oh, S., Tran, P. T., Kwon, M., . . . Kang, K. W. (2025). High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader. BMC.
Chicago Style (17th ed.) CitationPark, Jaewoo, et al. High Cereblon Expression in Neuroendocrine Cancer Confers Vulnerability to GSPT1 Molecular Glue Degrader. BMC, 2025.
MLA (9th ed.) CitationPark, Jaewoo, et al. High Cereblon Expression in Neuroendocrine Cancer Confers Vulnerability to GSPT1 Molecular Glue Degrader. BMC, 2025.
Warning: These citations may not always be 100% accurate.